早产儿支气管肺发育不良危险因素的探讨(3)
第1页 |
参见附件(3038KB,3页)。
[5]Jobe AJ. The new BPD: an arrest of lung development [J]. Pediatr Res,1999,46(6):641-643.
[6]Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition [J]. Semin Neonatol,2003,8(1):63-71.
[7]Cunha GS, Mezszagappa-Fiho F, Ribeiro JD. Risk factors for bronchopulm-
onary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life [J]. J Trop Pediatr,2005,51(61):334-340.
[8]Van Marter LJ. Epidemiology of bronchopulmonary dysplasia [J]. Semin Fetal Neonatal Med,2009,14(6):358-366.
[9]Koli K, Myllamiemi M, Keski-Oja J, et al. Transforming Growth Factor-beta Activation in the Lung: Focus on Fibrosis and Reactive Oxygen Species [J]. Antioxidants & Redox Signaling [Antioxid Redox Signal],2008,10(2):333-342.
[10]Stephens BE, Gargus RA, Walden RV, et al. Fluid regimens in the first week of life may increase risk of patent ductus arteriosus in extremely low birth weight infants [J]. J Perinatal,2008,28(2):123-128.
[11]Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia [J]. Lancet,2006,367(9520):1421-1431.
[12]Gagliardi L, Bellù R, Rusconi F, et al. Antenatal steroids and risk of bronchopulmonary dysplasia: a lack of effect or a case of over-adjustment [J]. Paediatr Perinat Epidemiol,2007,21(4):347-353.
(收稿日期:2011-02-16)
您现在查看是摘要介绍页,详见PDF附件(3038KB,3页)。